The metabolic triggers that causes enlarged hearts—a condition known as cardiac hypertrophy—remain elusive, but researchers at Purdue University are getting closer to solving this riddle.
The team led by Professor Dr. Klaus Kümmerer has now succeeded in developing antibiotics of this class of substances that become innocuous in the environment by natural degradation.
Bringing nature into the workplace can help reduce stress and increase creativity and focus, research shows.
Various types of lizard venom are being studied as possible treatments for blood clotting diseases that lead to millions of cases of stroke, heart attack, and deep-vein thrombosis annually.
A new book, co-authored by a UTA researcher, empirically shows how badly sprawl affects health and other quality-of-life outcomes.
Around 70 percent of deaths in Pacific Island countries are due to diabetes, heart disease, high blood pressure and cancer.
Researchers at Ben-Gurion University (BGU) and the Sheba Medical Center have developed a new therapy to treat atherosclerosis and prevent heart failure with a new biomedical polymer that reduces arterial plaque and inflammation ...
Who knew that co-workers who are neither friends nor enemies – especially those who float unpredictably between being both – can affect us more on the job than other colleagues?
Researchers hope to design a new generation of drugs against an array of deadly diseases. The task, however, is costly, arduous and often ineffective. One of the key challenges is understanding a particular class of proteins ...
Gene variants associated with disease are typically considered faulty; problems arise when the proteins they make don't adequately carry out their designated role. But a new biochemical study from Johns Hopkins researchers ...